SYS6002

· CSPC Megalith Biopharmaceutical Co.,Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for SYS6002, covering 2025-08-27 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: SYS6002 vs Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma [Phase 3]